Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,022 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
RFC1-related disorder presenting recurrent syncope.
Tsuboyama Y, Takahashi A, Furukawa S, Almansour A, Hamada M, Kubota A, Shimizu J, Kinoshita M, Fujimoto C, Mitsui J, Matsukawa T, Naruse H, Ishiura H, Tsuji S, Toda T. Tsuboyama Y, et al. Among authors: shimizu j. J Neurol. 2024 Mar 7. doi: 10.1007/s00415-024-12231-5. Online ahead of print. J Neurol. 2024. PMID: 38451278 No abstract available.
Safety and efficacy of eculizumab in Guillain-Barré syndrome: a multicentre, double-blind, randomised phase 2 trial.
Misawa S, Kuwabara S, Sato Y, Yamaguchi N, Nagashima K, Katayama K, Sekiguchi Y, Iwai Y, Amino H, Suichi T, Yokota T, Nishida Y, Kanouchi T, Kohara N, Kawamoto M, Ishii J, Kuwahara M, Suzuki H, Hirata K, Kokubun N, Masuda R, Kaneko J, Yabe I, Sasaki H, Kaida KI, Takazaki H, Suzuki N, Suzuki S, Nodera H, Matsui N, Tsuji S, Koike H, Yamasaki R, Kusunoki S; Japanese Eculizumab Trial for GBS (JET-GBS) Study Group. Misawa S, et al. Lancet Neurol. 2018 Jun;17(6):519-529. doi: 10.1016/S1474-4422(18)30114-5. Epub 2018 Apr 21. Lancet Neurol. 2018. PMID: 29685815 Clinical Trial.
Nerve ultrasound aids sural nerve biopsy in sarcoid neuropathy.
Kondo A, Hokkoku K, Mukai T, Uchida Y, Chiba T, Kitamura A, Kubota A, Hatanaka Y, Sonoo M, Shimizu J, Kobayashi S. Kondo A, et al. Among authors: shimizu j. J Neurol Sci. 2024 May 15;460:122984. doi: 10.1016/j.jns.2024.122984. Epub 2024 Apr 1. J Neurol Sci. 2024. PMID: 38580483 No abstract available.
Temporal changes and geographical differences in multiple sclerosis phenotypes in Japanese: nationwide survey results over 30 years.
Osoegawa M, Kira J, Fukazawa T, Fujihara K, Kikuchi S, Matsui M, Kohriyama T, Sobue G, Yamamura T, Itoyama Y, Saida T, Sakata K, Ochi H, Matsuoka T; Research Committee of Neuroimmunological Diseases. Osoegawa M, et al. Mult Scler. 2009 Feb;15(2):159-73. doi: 10.1177/1352458508098372. Epub 2008 Nov 5. Mult Scler. 2009. PMID: 18987106
Heterogeneity and continuum of multiple sclerosis phenotypes in Japanese according to the results of the fourth nationwide survey.
Ishizu T, Kira J, Osoegawa M, Fukazawa T, Kikuchi S, Fujihara K, Matsui M, Kohriyama T, Sobue G, Yamamura T, Itoyama Y, Saida T, Sakata K; Research Committee of Neuroimmunological Diseases. Ishizu T, et al. J Neurol Sci. 2009 May 15;280(1-2):22-8. doi: 10.1016/j.jns.2009.01.008. Epub 2009 Feb 7. J Neurol Sci. 2009. PMID: 19201428
ASO Author Reflections: Which was the Better Regimen (Gemcitabine Plus Nab-Paclitaxel Versus Gemcitabine Plus S-1) as Neoadjuvant Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma (R/BR-PDAC)?
Yamada D, Kobayashi S, Takahashi H, Iwagami Y, Akita H, Asukai K, Shimizu J, Yamada T, Tanemura M, Yokoyama S, Tsujie M, Asaoka T, Takeda Y, Morimoto O, Tomokuni A, Doki Y, Eguchi H. Yamada D, et al. Among authors: shimizu j. Ann Surg Oncol. 2024 May 9. doi: 10.1245/s10434-024-15244-6. Online ahead of print. Ann Surg Oncol. 2024. PMID: 38722422 No abstract available.
ASO Author Reflections: A Novel Mechanism of Anticancer Effect of Skeletal Muscle-Derived Irisin in Pancreatic Ductal Adenocarcinoma.
Sugimoto T, Iwagami Y, Kobayashi S, Yamanaka C, Sasaki K, Yamada D, Tomimaru Y, Asaoka T, Noda T, Takahashi H, Shimizu J, Doki Y, Eguchi H. Sugimoto T, et al. Among authors: shimizu j. Ann Surg Oncol. 2024 May 9. doi: 10.1245/s10434-024-15349-y. Online ahead of print. Ann Surg Oncol. 2024. PMID: 38722421 No abstract available.
Current challenges in the discovery of treatments against Mayaro fever.
Marques RE, Shimizu JF, Nogueira ML, Vasilakis N. Marques RE, et al. Among authors: shimizu jf. Expert Opin Ther Targets. 2024 May 8:1-12. doi: 10.1080/14728222.2024.2351504. Online ahead of print. Expert Opin Ther Targets. 2024. PMID: 38714500 Review.
1,022 results